1921
Volume 91, Issue 6
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract.

Madura foot is a chronic infection caused by fungus and/or bacteria. Traditionally, treatment has been surgical debridement or amputation. Non-invasive management with long-term antimicrobials alone has been reported as successful. We report a case of Madura foot in a Somali refugee successfully managed with oral posaconazole and ciprofloxacin.

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.14-0335
2014-12-03
2017-09-25
Loading full text...

Full text loading...

/deliver/fulltext/14761645/91/6/1259.html?itemId=/content/journals/10.4269/ajtmh.14-0335&mimeType=html&fmt=ahah

References

  1. Hershkovitz I, Speirs M, Katznelson A, Arensburg B, , 1992. Unusual pathological condition in the lower extremities of a skeleton from ancient Israel. Am J Phys Anthropol 88: 2326.[Crossref]
  2. Kaufman MH, , 2007. Sir George Ballingall (1786–1855): Regius Professor of Military Surgery in the University of Edinburgh. J Med Biogr 15: 7581.[Crossref]
  3. Ahmed AA, van de Sande WW, Fahal A, Bakker-Woudenberg I, Verbrugh H, van Belkum A, , 2007. Management of mycetoma: major challenge in tropical mycoses with limited international recognition. Curr Opin Infect Dis 20: 146151.[Crossref]
  4. McGinnis MR, , 1996. Mycetoma. Dermatol Clin 14: 97104.[Crossref]
  5. van de Sande WW, , 2013. Global burden of human mycetoma: a systematic review and meta-analysis. PLoS Negl Trop Dis 7: e2550.[Crossref]
  6. Ameen M, Arenas R, , 2009. Developments in the management of mycetomas. Clin Exp Dermatol 34: 17.[Crossref]
  7. Parker L, Singh D, Biz C, , 2009. The dot-in-circle sign in Madura foot. J Foot Ankle Surg 48: 690.e15.[Crossref]
  8. Mahgoub ES, , 1976. Medical management of mycetoma. Bull World Health Organ 54: 303310.
  9. Fahal AH, Shaheen S, Jones DH, , 2014. The orthopedic aspects of mycetoma. Bone Joint J 96-B: 420425.[Crossref]
  10. Garnica M, Nucci M, Queiroz-Telles F, , 2009. Difficult mycoses of the skin: advances in the epidemiology and management of eumycetoma, phaeohyphomycosis and chromoblastomycosis. Curr Opin Infect Dis 22: 559563.[Crossref]
  11. Keating GM, , 2005. Posaconazole. Drugs 65: 15531567, discussion 68–69.[Crossref]
  12. Negroni R, Tobon A, Bustamante B, Shikanai-Yasuda MA, Patino H, Restrepo A, , 2005. Posaconazole treatment of refractory eumycetoma and chromoblastomycosis. Rev Inst Med Trop Sao Paulo 47: 339346.[Crossref]
  13. Zoller E, Valente C, Baker K, Klepser ME, , 2010. Development, clinical utility, and place in therapy of posaconazole for prevention and treatment of invasive fungal infections. Drug Des Devel Ther 4: 299311.
  14. Jain V, Makwana GE, Bahri N, The MK, , 2012. “Dot-in-Circle” sign on MRI in maduramycosis: a characteristic finding. J Clin Imaging Sci. 2: 66.[Crossref]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.14-0335
Loading
/content/journals/10.4269/ajtmh.14-0335
Loading

Data & Media loading...

  • Received : 30 May 2014
  • Accepted : 29 Jun 2014

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error